BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17695489)

  • 1. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
    Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
    Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
    Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
    Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NBS1 variant I171V and breast cancer risk.
    Bogdanova N; Schürmann P; Waltes R; Feshchenko S; Zalutsky IV; Bremer M; Dörk T
    Breast Cancer Res Treat; 2008 Nov; 112(1):75-9. PubMed ID: 18049891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
    Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
    Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
    Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.
    Steffen J; Nowakowska D; Niwińska A; Czapczak D; Kluska A; Piatkowska M; Wiśniewska A; Paszko Z
    Int J Cancer; 2006 Jul; 119(2):472-5. PubMed ID: 16770759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
    Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
    Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer predisposing alleles in Poland.
    Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
    Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
    Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
    Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.
    Brozek I; Ochman K; Debniak J; Morzuch L; Ratajska M; Stepnowska M; Stukan M; Emerich J; Limon J
    Gynecol Oncol; 2008 Feb; 108(2):433-7. PubMed ID: 17997147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations.
    Medina PP; Ahrendt SA; Pollan M; Fernandez P; Sidransky D; Sanchez-Cespedes M
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):699-704. PubMed ID: 12917199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
    Romanowicz-Makowska H; Smolarz B; Kulig A
    Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.
    Kim TJ; Lee KM; Choi CH; Lee JW; Lee JH; Bae DS; Kim BG
    Oncol Rep; 2006 Mar; 15(3):565-9. PubMed ID: 16465413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Hartikainen JM; Kataja V; Pirskanen M; Arffman A; Ristonmaa U; Vahteristo P; Ryynänen M; Heinonen S; Kosma VM; Mannermaa A
    Clin Genet; 2007 Oct; 72(4):311-20. PubMed ID: 17850627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes.
    Porhanova NV; Sokolenko AP; Sherina NY; Ponomariova DN; Tkachenko NN; Matsko DE; Imyanitov EN
    Cancer Genet Cytogenet; 2008 Oct; 186(2):122-4. PubMed ID: 18940477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.